Turing Pharmaceuticals

Showing 6 posts of 6 posts found.


Price hiking: US pharma’s elephant in the room

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …

Shkreli hearing

Big pharma answers tough questions at US drug pricing hearing

February 5, 2016
Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress

Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …


Martin Shkreli resigns from Turing

December 21, 2015
Sales and Marketing Martin Shkreli, Shkreli, Turing Pharmaceuticals

Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing and been replaced by …


Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man

December 18, 2015
Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals

As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …


Turing faces antitrust probe over Daraprim price hike

October 14, 2015
Sales and Marketing Daraprim, Turing Pharmaceuticals, turing

Turing Pharmaceuticals, the drug company that increased the price of the generic drug Daraprim 50-fold overnight, is facing an antitrust …


Turing will drop price of Daraprim following outrage

September 24, 2015
Sales and Marketing Daraprim, Impax Laboratories, Martin Shkreli, Turing Pharmaceuticals, toxoplasmosis

Martin Shkreli, whose company Turing Pharmaceuticals increased the price of Daraprim more than fifty-fold overnight, has been forced to backpedal …

Latest content